CME Statistics
Share Statistics
CME has 360.36M
shares outstanding. The number of shares has increased by 0.09%
in one year.
| Shares Outstanding | 360.36M |
| Shares Change (YoY) | 0.09% |
| Shares Change (QoQ) | 0.01% |
| Owned by Institutions (%) | 88.29% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 11 |
| FTD / Avg. Volume | n/a |
Short Selling Information
The latest short interest is 4.96M, so 1.38% of the outstanding
shares have been sold short.
| Short Interest | 4.96M |
| Short % of Shares Out | 1.38% |
| Short % of Float | 1.38% |
| Short Ratio (days to cover) | 1.34 |
Valuation Ratios
The PE ratio is 23.67 and the forward
PE ratio is 25.46.
CME's PEG ratio is
2.56.
| PE Ratio | 23.67 |
| Forward PE | 25.46 |
| PS Ratio | 13.61 |
| Forward PS | 12.5 |
| PB Ratio | 3.15 |
| P/FCF Ratio | 23.21 |
| PEG Ratio | 2.56 |
Financial Ratio HistoryEnterprise Valuation
CME has an Enterprise Value (EV) of 84B.
| EV / Sales | 13.7 |
| EV / EBITDA | 18.21 |
| EV / EBIT | 22.76 |
| EV / FCF | 23.36 |
Financial Position
The company has a current ratio of 1.01,
with a Debt / Equity ratio of 0.13.
| Current Ratio | 1.01 |
| Quick Ratio | 1.01 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 0.74 |
| Debt / FCF | 0.95 |
| Interest Coverage | 24.43 |
Financial Efficiency
Return on Equity is 13.31% and Return on Invested Capital is 8.51%.
| Return on Equity | 13.31% |
| Return on Assets | 2.57% |
| Return on Invested Capital | 8.51% |
| Revenue Per Employee | $1,630,345.74 |
| Profits Per Employee | $937,712.77 |
| Employee Count | 3,760 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 1.02B |
| Effective Tax Rate | 22.36% |
Stock Price Statistics
The stock price has increased by 32% in the
last 52 weeks. The beta is 0.47, so CME's
price volatility has been higher than the market average.
| Beta | 0.47 |
| 52-Week Price Change | 32% |
| 50-Day Moving Average | 263.6 |
| 200-Day Moving Average | 235.06 |
| Relative Strength Index (RSI) | 68.42 |
| Average Volume (20 Days) | 2,567,265 |
Income Statement
In the last 12 months, CME had revenue of 6.13B
and earned 3.53B
in profits. Earnings per share was 9.69.
| Revenue | 6.13B |
| Gross Profit | 5.28B |
| Operating Income | 3.93B |
| Net Income | 3.53B |
| EBITDA | 4.61B |
| EBIT | 4.7B |
| Earnings Per Share (EPS) | 9.69 |
Full Income StatementBalance Sheet
The company has 2.89B in cash and 3.43B in
debt, giving a net cash position of -535.6M.
| Cash & Cash Equivalents | 2.89B |
| Total Debt | 3.43B |
| Net Cash | -535.6M |
| Retained Earnings | 4.19B |
| Total Assets | 157.83B |
| Working Capital | 2.03B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 3.69B
and capital expenditures 0, giving a free cash flow of 3.6B.
| Operating Cash Flow | 3.69B |
| Capital Expenditures | n/a |
| Free Cash Flow | 3.6B |
| FCF Per Share | 10.01 |
Full Cash Flow StatementMargins
Gross margin is 86.13%, with operating and profit margins of 64.13% and 57.52%.
| Gross Margin | 86.13% |
| Operating Margin | 64.13% |
| Pretax Margin | 74.08% |
| Profit Margin | 57.52% |
| EBITDA Margin | 75.24% |
| EBIT Margin | 64.13% |
| FCF Margin | 58.67% |
Dividends & Yields
CME pays an annual dividend of $11.65,
which amounts to a dividend yield of 4.12%.
| Dividend Per Share | $11.65 |
| Dividend Yield | 4.12% |
| Dividend Growth (YoY) | 8.7% |
| Payout Ratio | 117.09% |
| Earnings Yield | 4.22% |
| FCF Yield | 4.31% |
Dividend DetailsAnalyst Forecast
The average price target for CME is $263,
which is -6.7% lower than the current price. The consensus rating is "Hold".
| Price Target | $263 |
| Price Target Difference | -6.7% |
| Analyst Consensus | Hold |
| Analyst Count | 23 |
Stock ForecastsStock Splits
The last stock split was on Jul 23, 2012. It was a
forward
split with a ratio of 5:1.
| Last Split Date | Jul 23, 2012 |
| Split Type | forward |
| Split Ratio | 5:1 |
Scores
| Altman Z-Score | 0.65 |
| Piotroski F-Score | 7 |
